<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38739263</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Characterization of cognitive symptoms in post COVID-19 patients.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-024-01821-z</ELocationID><Abstract><AbstractText>Cognitive symptoms (CS) belong to the most common manifestations of the Post COVID-19 (PC) condition. We sought to objectify CS in PC patients using routine diagnostic assessments: neurocognitive testing (NCT) and brain imaging (BI). Further, we investigated possible associations of CS with patient reported outcomes (PROs), and risk factors for developing CS. Clinical data and PROs of 315 PC patients were assessed at a mean of 6 months after SARS-CoV-2 infection. 231 (73.3%) patients reported any sort of CS. Among them, 78 underwent NCT and 55 received BI. In NCT, the cognitive domains most affected&#xa0;were the working memory, attention, and concentration. Nonetheless, pathological thresholds were exceeded only in few cases. Neurocognitive performance did not differ significantly between patients complaining of severe (n&#x2009;=&#x2009;26) versus non-severe (n&#x2009;=&#x2009;52) CS. BI findings were abnormal in 8 (14.5%) cases with CS but were most likely not related to PC. Patients reporting high severity of CS scored worse in the PHQ-9, FSS, WHOQOL-BREF, were more likely to report impaired sleep, and had a higher prevalence of psychiatric diagnoses. Overall, NCT could confirm mild impairment in some but not all PC patients with CS, while BI studies were abnormal in only few cases. CS severity did not affect NCT results, but severe CS were associated with symptoms of depression (PHQ-9), fatigue (FSS), reduced quality of life (WHOQOL-BREF) and higher prevalence of psychiatric illnesses. These findings support the importance of NCT, BI, and neuro-psychological assessment in the work-up of PC patients reporting CS. TRIAL REGISTRATION: Trial registration number and date of registration: DRKS00030974, 22 Dec 2022, retrospectively registered.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruzicka</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2451-1070</Identifier><AffiliationInfo><Affiliation>Department of Medicine III, Ludwig Maximilian University (LMU) University Hospital, LMU Munich, Munich, Germany. michael.ruzicka@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachenbacher</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heimkes</LastName><ForeName>Fides</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uebleis</LastName><ForeName>Aline Olivia</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosse-Wentrup</LastName><ForeName>Fabienne</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarra Fonseca</LastName><ForeName>Gerardo Jesus</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wunderlich</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogner</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayerle</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Bergwelt-Baildon</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine III, Ludwig Maximilian University (LMU) University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falkai</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subklewe</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine III, Ludwig Maximilian University (LMU) University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzicka</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benesch</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdinoci</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernpruner</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heindl</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Stabstelle Strategische Unternehmenssteuerung, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Stubbe</LastName><ForeName>Hans Christian</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Adorjan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID-19 syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>12</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>12</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38739263</ArticleId><ArticleId IdType="doi">10.1007/s00406-024-01821-z</ArticleId><ArticleId IdType="pii">10.1007/s00406-024-01821-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO (2020) WHO Director-General's opening remarks at the media briefing on COVID-19&#x2014;11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 . Accessed 8 Mar 2023</Citation></Reference><Reference><Citation>WHO (2022) Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed 19 Apr 2023</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601&#x2013;615. https://doi.org/10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A et al (2023) The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 55:101762. https://doi.org/10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC (2022) Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data stratified by recruitment setting. ECDC, Stockholm</Citation></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM et al (2022) Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93&#x2013;135. https://doi.org/10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Caruso MJG, Cincoto AV, de Almeida Rocca CC, de Padua SA, Bacchi P et al (2022) Post-COVID-19 psychiatric and cognitive morbidity: preliminary findings from a Brazilian cohort study. Gen Hosp Psychiatry 75:38&#x2013;45. https://doi.org/10.1016/j.genhosppsych.2022.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.01.002</ArticleId><ArticleId IdType="pubmed">35134702</ArticleId><ArticleId IdType="pmc">8734055</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Cuevas C, Oliver-Mas S, Diez-Cirarda M, Delgado-Alvarez A, Gil-Moreno MJ et al (2022) Fatigue and cognitive dysfunction are associated with occupational status in post-COVID syndrome. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph192013368</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192013368</ArticleId><ArticleId IdType="pubmed">36293950</ArticleId><ArticleId IdType="pmc">9603617</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Diez-Cirarda M, Pagan J, Perez-Izquierdo C, Oliver-Mas S, Fernandez-Romero L et al (2023) Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. Eur J Neurol. https://doi.org/10.1111/ene.16084</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.16084</ArticleId><ArticleId IdType="pubmed">37797297</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A et al (2022) Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection 50(3):661&#x2013;669. https://doi.org/10.1007/s15010-021-01733-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01733-3</ArticleId><ArticleId IdType="pubmed">34997542</ArticleId><ArticleId IdType="pmc">8741139</ArticleId></ArticleIdList></Reference><Reference><Citation>Scardua-Silva L, Amorim da Costa B, Karmann Aventurato I, Batista Joao R, Machado de Campos B, Rabelo de Brito M, et al. Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19. Sci Rep. 2024;14(1):1758. doi: https://doi.org/10.1038/s41598-024-52005-7 .</Citation></Reference><Reference><Citation>Shan D, Li S, Xu R, Nie G, Xie Y, Han J et al (2022) Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies. Front Aging Neurosci 14:1077384. https://doi.org/10.3389/fnagi.2022.1077384</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1077384</ArticleId><ArticleId IdType="pubmed">36570532</ArticleId><ArticleId IdType="pmc">9780393</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Cirarda M, Yus M, Gomez-Ruiz N, Polidura C, Gil-Martinez L, Delgado-Alonso C et al (2023) Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain 146(5):2142&#x2013;2152. https://doi.org/10.1093/brain/awac384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac384</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604(7907):697&#x2013;707. https://doi.org/10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>RKI: SARS-CoV-2: Virologische Basisdaten sowie Virusvarianten im Zeitraum von 2020 - 2022. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Virologische_Basisdaten.html?nn=13490888#doc14716546bodyText9 (2023). Accessed December 4th, 2023.</Citation></Reference><Reference><Citation>Schmidt K, Metzler P. WST-Wortschatztest. Goettingen, Germany: Beltz Test; 1992.</Citation></Reference><Reference><Citation>Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20(3):310&#x2013;319. https://doi.org/10.1076/jcen.20.3.310.823</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.20.3.310.823</ArticleId><ArticleId IdType="pubmed">9845158</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan R (1958) Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept Mot Skills 8(3):271&#x2013;276. https://doi.org/10.2466/pms.1958.8.3.271</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.1958.8.3.271</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54(2):159&#x2013;165. https://doi.org/10.1001/archpsyc.1997.01830140071013</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1997.01830140071013</ArticleId><ArticleId IdType="pubmed">9040284</ArticleId></ArticleIdList></Reference><Reference><Citation>Brickenkamp R, Schmidt-Atzert L, Liepmann D (2010) Test d2-Revision: Aufmerksamkeits-und Konzentrationstest. Hofgrefe, Goettingen, Germany</Citation></Reference><Reference><Citation>Lehrl S, Triebig G, Fischer B (1995) Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand 91(5):335&#x2013;345. https://doi.org/10.1111/j.1600-0404.1995.tb07018.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1995.tb07018.x</ArticleId><ArticleId IdType="pubmed">7639062</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2023) WHOQOL: Measuring quality of life. https://www.who.int/tools/whoqol/whoqol-bref . Accessed 8 Mar 2023</Citation></Reference><Reference><Citation>Costantini L, Pasquarella C, Odone A, Colucci ME, Costanza A, Serafini G et al (2021) Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): a systematic review. J Affect Disord 279:473&#x2013;483. https://doi.org/10.1016/j.jad.2020.09.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.09.131</ArticleId><ArticleId IdType="pubmed">33126078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606&#x2013;613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId><ArticleId IdType="pmc">1495268</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121&#x2013;1123. https://doi.org/10.1001/archneur.1989.00520460115022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado MO, Kang NC, Tai F, Sambhi RDS, Berk M, Carvalho AF et al (2021) Measuring fatigue: a meta-review. Int J Dermatol 60(9):1053&#x2013;1069. https://doi.org/10.1111/ijd.15341</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15341</ArticleId><ArticleId IdType="pubmed">33301180</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2020) International statistical classification of diseases and related health problems 10th revision (ICD-10)-WHO Version for 2019&#x2014;Covid-expanded. https://icd.who.int/browse10/2019/en#/F51.0 . Accessed 22 Nov 2023</Citation></Reference><Reference><Citation>Roth T (2007) Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med 3(5 Suppl):S7-10</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.26929</ArticleId><ArticleId IdType="pubmed">17824495</ArticleId><ArticleId IdType="pmc">1978319</ArticleId></ArticleIdList></Reference><Reference><Citation>LEOSS (2020) Definition of clinical phases and distribution at diagnosis. https://leoss.net/statistics/ . Accessed 5 Dec 2023</Citation></Reference><Reference><Citation>Dressing A, Bormann T, Blazhenets G, Schroeter N, Walter LI, Thurow J et al (2022) Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome. J Nucl Med 63(7):1058&#x2013;1063. https://doi.org/10.2967/jnumed.121.262677</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262677</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId><ArticleId IdType="pmc">9258569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M, Cano N, Segura B, Adan A, Bargallo N, Caldu X et al (2022) Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints. Front Aging Neurosci 14:1029842. https://doi.org/10.3389/fnagi.2022.1029842</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1029842</ArticleId><ArticleId IdType="pubmed">36337708</ArticleId><ArticleId IdType="pmc">9631485</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu JA, Herrera E, Gonzalez-Nosti M, Krishnan K, Delgado-Alonso C, Diez-Cirarda M et al (2023) Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach. Psychiatry Res 319:115006. https://doi.org/10.1016/j.psychres.2022.115006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.115006</ArticleId><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Toniolo S, Hampshire A, Husain M (2023) Effects of COVID-19 on cognition and brain health. Trends Cogn Sci 27(11):1053&#x2013;1067. https://doi.org/10.1016/j.tics.2023.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2023.08.008</ArticleId><ArticleId IdType="pubmed">37657964</ArticleId><ArticleId IdType="pmc">10789620</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A (2022) Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. https://doi.org/10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pubmed">36558822</ArticleId><ArticleId IdType="pmc">9699461</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT (1963) Thinking and depression. I. Idiosyncratic content and cognitive distortions. Arch Gen Psychiatry 9:324&#x2013;333. https://doi.org/10.1001/archpsyc.1963.01720160014002</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1963.01720160014002</ArticleId><ArticleId IdType="pubmed">14045261</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Haigh EA (2014) Advances in cognitive theory and therapy: the generic cognitive model. Annu Rev Clin Psychol 10:1&#x2013;24. https://doi.org/10.1146/annurev-clinpsy-032813-153734</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-clinpsy-032813-153734</ArticleId><ArticleId IdType="pubmed">24387236</ArticleId></ArticleIdList></Reference><Reference><Citation>MacQueen GM, Memedovich KA (2017) Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. Psychiatry Clin Neurosci 71(1):18&#x2013;27. https://doi.org/10.1111/pcn.12463</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.12463</ArticleId><ArticleId IdType="pubmed">27685435</ArticleId></ArticleIdList></Reference><Reference><Citation>Culpepper L, Lam RW, McIntyre RS (2017) Cognitive impairment in patients with depression: awareness, assessment, and management. J Clin Psychiatry 78(9):1383&#x2013;1394. https://doi.org/10.4088/JCP.tk16043ah5c</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.tk16043ah5c</ArticleId><ArticleId IdType="pubmed">29345866</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Best MW, Bowie CR, Carmona NE, Cha DS, Lee Y et al (2017) The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry 78(7):873&#x2013;881. https://doi.org/10.4088/JCP.16m11329</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.16m11329</ArticleId><ArticleId IdType="pubmed">28858441</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownlow JA, Miller KE, Gehrman PR (2020) Insomnia and cognitive performance. Sleep Med Clin 15(1):71&#x2013;76. https://doi.org/10.1016/j.jsmc.2019.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsmc.2019.10.002</ArticleId><ArticleId IdType="pubmed">32005351</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedjasukmana R, Budikayanti A, Islamiyah WR, Witjaksono A, Hakim M (2022) Sleep disturbance in post COVID-19 conditions: prevalence and quality of life. Front Neurol 13:1095606. https://doi.org/10.3389/fneur.2022.1095606</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1095606</ArticleId><ArticleId IdType="pubmed">36698905</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J et al (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci 434:120162. https://doi.org/10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId><ArticleId IdType="pmc">8798975</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. https://doi.org/10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId><ArticleId IdType="pmc">8280690</ArticleId></ArticleIdList></Reference><Reference><Citation>Okrzeja J, Garkowski A, Kubas B, Moniuszko-Malinowska A (2023) Imaging and neuropathological findings in patients with POST COVID-19 neurological syndrome&#x2014;a review. Front Neurol 14:1136348. https://doi.org/10.3389/fneur.2023.1136348</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1136348</ArticleId><ArticleId IdType="pubmed">36846139</ArticleId><ArticleId IdType="pmc">9947471</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>